Related Experiment Video
Updated: Jun 13, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Altered-function p53 missense mutations identified in breast cancers can have subtle effects on transactivation
Jennifer J Jordan1, Alberto Inga, Kathleen Conway
1Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina 27709, USA.
Mutations in the tumor suppressor p53 impact gene regulation and cell stress responses. Functional analysis of breast cancer p53 mutants reveals diverse transactivation defects, potentially influencing clinical outcomes.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Mutations in the tumor suppressor p53 can alter its transactivation function, affecting gene activation and cellular responses to stress.
- p53 mutations are implicated in various cancers, including sporadic breast cancer and familial syndromes like Li-Fraumeni.
Purpose of the Study:
- To determine the functional fingerprints of sporadic breast cancer-associated p53 mutants.
- To assess the transactivation ability of wild-type and mutant p53 across 11 human target response elements (REs).
Main Methods:
- Utilized a cellular, isogenomic yeast model system for rapid analysis of p53 function.
- Assessed p53 transactivation at variable expression levels using qualitative and quantitative reporters.
- Analyzed 50 missense p53 mutants.
Main Results:
- 29 out of 50 missense mutants showed a loss of function.
- 21 mutants retained transactivation toward at least one RE.
- Subtle transactivation defects were revealed in some mutants at reduced expression levels, suggesting altered transcriptional activity.
Conclusions:
- Functional heterogeneity exists among p53 mutants found in breast cancer.
- Specific p53 mutation functionality may correlate with clinical parameters such as demographics, tumor appearance, and relapse rates.
- These findings suggest p53 mutation status could impact clinical behavior and treatment outcomes.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
